Analysts Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) PT at $31.25
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Rating) have been assigned an average recommendation of “Buy” from the fifteen ratings firms that are covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The average twelve-month price […]